www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

Annual General Meeting in ALK-Abelló A/S held on 15 March 2017

March 15, 2017

PDF Version

Supporting Materials:
FM_09_17UK_15032017.pdf

 

 

Copenhagen, 2017-03-15 17:13 CET (GLOBE NEWSWIRE) --  

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) held its annual general meeting on 15 March 2017. 

The annual general meeting transacted the following business: 

  • Adoption of the annual report 2016 and discharge of the Board of Directors and Board of Management.
     
  • Declaration of an ordinary dividend of DKK 5.00 per A/B share of DKK 10.
     
  • Approval of the remuneration to the Board of Directors for the present year. The remuneration remains unchanged compared to 2016. 
  • Re-election of Steen Riisgaard as Chairman of the Board of Directors. 
  • Re-election of Lene Skole as Vice Chairman of the Board of Directors.
     
  • Re-election of Lars Holmqvist, Anders Gersel Pedersen, Jakob Riis and Per Valstorp to the Board of Directors.
     
  • Re-appointment of DELOITTE Statsautoriseret Revisionspartnerselskab as the company's auditor.
     
  • Adoption of the following proposals from the Board of Directors:
    a) adjustments to the general guidelines for incentive pay to the Board of Directors and the Board of Management
    b) updated remuneration guidelines for the Board of Directors and the Board of Management
    c) sign on fee of DKK 10.8 million consisting of DKK 1.5 million cash and share options for the new President & CEO Carsten Hellmann.
     

  
ALK-Abelló A/S
 

For further information please contact:
Steen Riisgaard, Chairman, tel. +45 4574 7576

 

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved